SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-038958
Filing Date
2020-08-10
Accepted
2020-08-10 16:31:44
Documents
77
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q adpt-10q_20200630.htm   iXBRL 10-Q 2888881
2 EX-10.1 adpt-ex101_139.htm EX-10.1 58188
3 EX-31.1 adpt-ex311_138.htm EX-31.1 24790
4 EX-31.2 adpt-ex312_137.htm EX-31.2 26199
5 EX-32.1 adpt-ex321_135.htm EX-32.1 11625
6 EX-32.2 adpt-ex322_136.htm EX-32.2 13079
  Complete submission text file 0001564590-20-038958.txt   9672558

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA adpt-20200630.xsd EX-101.SCH 56994
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adpt-20200630_cal.xml EX-101.CAL 55789
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adpt-20200630_def.xml EX-101.DEF 205434
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20200630_lab.xml EX-101.LAB 444956
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20200630_pre.xml EX-101.PRE 363326
12 EXTRACTED XBRL INSTANCE DOCUMENT adpt-10q_20200630_htm.xml XML 1844609
Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 201089840
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences